Tech Company Financing Transactions
Avalyn Pharma Funding Round
Eventide Asset Management, Perceptive Xontogeny Venture Fund and SR One Capital Management participated in a $175 million Series C funding round for Avalyn Pharma. The funding round was announced on 9/27/2023.
Eventide Asset Management (Lead Investor)
Perceptive Xontogeny Venture Fund (Lead Investor)
SR One Capital Management (Lead Investor)
Seattle, WA 98101
Browse more venture capital transactions:
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs